Package 70518-4382-0

Brand: amlodipine besylate and benazepril hydrochloride

Generic: amlodipine besylate and benazepril hydrochloride
NDC Package

Package Facts

Identity

Package NDC 70518-4382-0
Digits Only 7051843820
Product NDC 70518-4382
Description

90 CAPSULE in 1 BOTTLE, PLASTIC (70518-4382-0)

Marketing

Marketing Status
Marketed Since 2025-07-02
Brand amlodipine besylate and benazepril hydrochloride
Generic amlodipine besylate and benazepril hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "38f40a6d-65ab-3693-e063-6394a90a84c5", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898346"], "spl_set_id": ["0f253cac-67ac-4b03-b1a8-f2c345938dda"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE, PLASTIC (70518-4382-0)", "package_ndc": "70518-4382-0", "marketing_start_date": "20250702"}], "brand_name": "Amlodipine Besylate and Benazepril Hydrochloride", "product_id": "70518-4382_38f40a6d-65ab-3693-e063-6394a90a84c5", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "70518-4382", "generic_name": "Amlodipine Besylate and Benazepril Hydrochloride", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine Besylate and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "10 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "40 mg/1"}], "application_number": "ANDA078466", "marketing_category": "ANDA", "marketing_start_date": "20250702", "listing_expiration_date": "20261231"}